Common Uses: This medicine is a sulfonamide used to treat ulcerative colitis, Crohn's disease, and rheumatoid arthritis. It may also be used to treat other conditions as determined by your doctor.

Generic Name: E: SULFASALAZINE (sul-fa-SAL-a-zeen)

[Sulfasalazine]. Medications should only be taken in accordance with the advice of your medical professional.

Buy Drugs Online Without Prescription - Click Here!

More about Sulfasalazine :

How to use this Medicine: Follow the directions for using this medicine provided by your doctor. TAKE THIS MEDICINE WITH FOOD and a full glass of water. DRINKING EXTRA FLUIDS while you are taking this medicine is recommended. Check with your doctor or nurse for instructions. SPACE YOUR DOSES EVENLY over each 24 hour period. If possible, try not to space any dose more than 8 hours from the next dose. STORE THIS MEDICINE at room temperature in a tightly-closed container, away from heat and light. IF YOU MISS A DOSE OF THIS MEDICINE, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Mexican name is Azulfidina

Cautions: TELL YOUR DOCTOR OR PHARMACIST IF YOU ARE ALLERGIC to sulfonamides (sulfa drugs) before taking this medicine. DO NOT TAKE THIS MEDICINE IF YOU HAVE HAD A SEVERE ALLERGIC REACTION to aspirin or any medicine containing aspirin. A severe reaction includes a severe rash, hives, breathing difficulties, or dizziness. If you have a question about whether you are allergic to this medicine, contact your doctor or pharmacist. KEEP ALL DOCTOR AND LABORATORY APPOINTMENTS while you are using this medicine. DRINKING EXTRA FLUIDS while you are taking this medicine is recommended. Check with your doctor or nurse for instructions. THIS MEDICINE MAY CAUSE increased sensitivity to the sun. Avoid exposure to the sun or sunlamps until you know how you react to this medicine. Use a sunscreen or protective clothing if you must be outside for a prolonged period. THIS MEDICINE MAY CAUSE a harmless, yellow-orange discoloration of the urine or skin. IF YOU EXPERIENCE difficulty breathing or tightness of chest; swelling of eyelids, face, or lips; or develop a rash or hives, tell your doctor immediately and before taking any more of this medicine. FOR WOMEN: THIS MEDICINE IS EXCRETED IN BREAST MILK. DO NOT BREAST-FEED while taking this medicine.

Possible Side Effects: SIDE EFFECTS, that may go away during treatment, include nausea, mild abdominal discomfort or pain, mild diarrhea, loss of appetite, or vomiting. If they continue or are bothersome, check with your doctor. Rarely, this medicine can cause serious, even fatal, side effects such as a severe peeling skin rash known as Stevens-Johnson syndrome, blood disorders (e.g., agranulocytosis, aplastic anemia), or liver damage. CONTACT YOUR DOCTOR IMMEDIATELY if you experience skin rash or blisters, unusual fatigue, persistent sore throat or fever, yellowing eyes or skin, dark urine, or abdominal pain. CHECK WITH YOUR DOCTOR AS SOON AS POSSIBLE if you experience tightness of chest, difficulty breathing, severe headache, or itching. If you notice other effects not listed above, contact your doctor, nurse, or pharmacist.

500mg 60 Tablets

For years, Americans living near Canada and Mexico have taken advantage of the low cost No Prescription Required available across the border, allowing them to purchase brand name and generic medicines like Sulfasalazine at substantial savings compare to prices in the United States. You must only take medications in accordance with the advice of your doctor or medical professional and you must only take No Prescription Required if you are in possession of a valid prescription.

[Sulfasalazine]

coloradoreview.com makes no endorsements, representations or warranties regarding any services or products offered at any online pharmacies.

< Previous  Next >  |  Back to Index

Drugs Online No Prescription Required - Buy discount no prescription required drugs online and purchase your pharmacy medications today!

In what can be termed as a rude wake-up call for millions of patients taking medication, five out of six approved prescription drugs seldom benefit them, claims a new study. According to experts, despite stringent reforms to shield the public from harmful drugs, the harm-benefit ratio is worsening due to relaxed rules that allow companies to promote drugs for unapproved uses. It’s really a two-tier market for lemons.” Systematic review conducted. Light carried out systematic reviews based on a wide range of data from independent sources and studies. The findings indicate that only one in six new drugs is superior to existing drugs. Most of the new drugs result in side effects serious enough to warrant action by the health regulators, including black box warnings, adverse reaction warnings, or even withdrawal of the drug. Citing the example of chloresterol-lowering statins, Light stated that drugs companies had reduced the link between heart disease, saturated fats and cholesterol into a simple refrain that "cholesterol kills". However, two clinical trials of statins were unable to establish that they cut the risk of heart attacks. One major meta-analysis of a number of studies, found that "statins were not associated with reduction in the risk of all-cause mortality.” Clinical trials flawed - Light accuses pharmaceutical companies of designing flawed clinical trials that minimize evidence of toxic side effects. Many a times the companies test the new drugs on a healthier population atypical of patients who will actually take the drug, excluding people who are older, poorer or who have multiple health problems. Trials are run just long enough to highlight the main benefits but not long enough to detect some long term side effects. Approvals are based on these data, drugs with harmful effects sometimes get through. Light stated, "The result is that drugs get approved without anyone being able to know how effective they really are or how much serious harm they will cause." The findings of the study were presented on Aug. 17 at the 105th Annual Meeting of the American Sociological Association in Atlanta.